Ultragenyx Pharmaceutical (RARE) Cash & Equivalents Growth (1y) (2014 - 2026)
Ultragenyx Pharmaceutical (RARE) Cash & Equivalents Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 988.88% |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -68.22% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 3.35% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 4.77% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 269.98% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.50% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ultragenyx Pharmaceutical | 2.77 Bn | 2.36 Bn | 106.00 Mn | 37.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.80% |
| Dec 31, 2025 | 141.95% |
| Sep 30, 2025 | 34.45% |
| Jun 30, 2025 | -63.32% |
| Mar 31, 2025 | 13.14% |
| Dec 31, 2024 | -18.69% |
| Sep 30, 2024 | 107.54% |
| Jun 30, 2024 | 371.00% |
| Mar 31, 2024 | 30.88% |
| Dec 31, 2023 | 60.97% |
| Sep 30, 2023 | -81.47% |
| Jun 30, 2023 | -36.16% |
| Mar 31, 2023 | -44.30% |
| Dec 31, 2022 | -56.78% |
| Sep 30, 2022 | 98.27% |
| Jun 30, 2022 | -45.04% |
| Mar 31, 2022 | -59.88% |
| Dec 31, 2021 | -56.89% |
| Sep 30, 2021 | 0.03% |
| Jun 30, 2021 | -13.34% |